Kamada (KMDA) Retained Earnings (2012 - 2026)
Kamada's (KMDA) quarterly Retained Earnings came in at -$27.4 million in Q1 2026, up 17.85% YoY from -$23.2 million in Q1 2025, and down 60.26% on a QoQ basis from -$17.1 million in Q4 2025.
Kamada (KMDA) Retained Earnings (2012 - 2026) Analysis & Trends
Kamada (KMDA) has 15 years of Retained Earnings data on file, last reported at -$27.4 million in Q1 2026.
- Quarterly Retained Earnings rose 17.85% year-over-year to -$27.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$27.4 million (up 17.85% YoY) and the FY2025 annual result came in at -$17.1 million, up 33.66% from the prior year.
- Retained Earnings fell to -$27.4 million in Q1 2026, from -$17.1 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$50293.0 in Q1 2023 to a low of -$51.9 million in Q2 2022.
- A 5-year average of -$31.4 million and a median of -$33.3 million in 2025 frame the typical range for Retained Earnings.
- The widest YoY moves for Retained Earnings: up 99.9% in 2023, down 87902.64% in 2023.
- Tracing KMDA's Retained Earnings over 5 years: stood at -$48.5 million in 2022, then gained by 17.09% to -$40.2 million in 2023, then surged by 35.98% to -$25.7 million in 2024, then jumped by 33.66% to -$17.1 million in 2025, then sank by 60.26% to -$27.4 million in 2026.
- The last three Retained Earnings figures came in at -$27.4 million (Q1 2026), -$17.1 million (Q4 2025), and -$20.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 3.75 Bn |
| 10 | Kamada | 463.48 Mn | 434.00 Mn | 22.47 Mn | 268.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 268.40 Mn |
| Mar 31, 2026 | -27.36 Mn |
| Dec 31, 2025 | -17.07 Mn |
| Sep 30, 2025 | -20.64 Mn |
| Jun 30, 2025 | -25.93 Mn |
| Mar 31, 2025 | -33.31 Mn |
| Dec 31, 2024 | -25.74 Mn |
| Sep 30, 2024 | -29.55 Mn |
| Jun 30, 2024 | -33.41 Mn |
| Mar 31, 2024 | -37.84 Mn |
| Dec 31, 2023 | -40.20 Mn |
| Sep 30, 2023 | -45.26 Mn |
| Jun 30, 2023 | -48.48 Mn |
| Mar 31, 2023 | -50,293.00 |
| Dec 31, 2022 | -48.48 Mn |
| Sep 30, 2022 | -51,428.00 |
| Jun 30, 2022 | -51.91 Mn |
| Mar 31, 2022 | -47.99 Mn |
| Dec 31, 2021 | -46.16 Mn |
| Sep 30, 2021 | -41.15 Mn |